236 related articles for article (PubMed ID: 31605340)
21. Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients.
Morrow M; Van Zee KJ; Patil S; Petruolo O; Mamtani A; Barrio AV; Capko D; El-Tamer M; Gemignani ML; Heerdt AS; Kirstein L; Pilewskie M; Plitas G; Sacchini VS; Sclafani LM; Ho A; Cody HS
Ann Surg; 2017 Sep; 266(3):457-462. PubMed ID: 28650355
[TBL] [Abstract][Full Text] [Related]
22. Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result.
Lim GH; Upadhyaya VS; Acosta HA; Lim JMA; Allen JC; Leong LCH
Eur J Surg Oncol; 2018 Jul; 44(7):945-950. PubMed ID: 29705286
[TBL] [Abstract][Full Text] [Related]
23. Axillary lymph node dissection can be omitted in patients with limited clinically node-positive breast cancer: a National Cancer Database analysis.
Cocco D; Shah C; Wei W; Wilkerson A; Grobmyer SR; Al-Hilli Z
Br J Surg; 2022 Nov; 109(12):1293-1299. PubMed ID: 36066266
[TBL] [Abstract][Full Text] [Related]
24. Regional nodal irradiation for early breast cancer; clinical benefit according to risk stratification.
Bartelink H
Breast; 2019 Nov; 48 Suppl 1():S65-S68. PubMed ID: 31839164
[TBL] [Abstract][Full Text] [Related]
25. Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial.
Shah-Khan M; Boughey JC
Cancer Control; 2012 Oct; 19(4):267-76. PubMed ID: 23037494
[TBL] [Abstract][Full Text] [Related]
26. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
[TBL] [Abstract][Full Text] [Related]
27. Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study.
Peng Y; Liu M; Li X; Tong F; Cao Y; Liu P; Zhou B; Liu H; Cheng L; Guo J; Xie F; Yang H; Wang S; Wang C; Chen Y; Wang S
World J Surg Oncol; 2021 Apr; 19(1):128. PubMed ID: 33879180
[TBL] [Abstract][Full Text] [Related]
28. Extranodal Tumor Deposits in the Axillary Fat Indicate the Need for Axillary Dissection Among T1-T2cN0 Patients with Positive Sentinel Nodes.
Mamtani A; Barrio AV; Goldman DA; Wen HY; Vincent A; Morrow M
Ann Surg Oncol; 2020 Oct; 27(10):3585-3592. PubMed ID: 32488512
[TBL] [Abstract][Full Text] [Related]
29. Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
Gingras I; Holmes E; De Azambuja E; Nguyen DH; Izquierdo M; Anne Zujewski J; Inbar M; Naume B; Tomasello G; Gralow JR; Wolff AC; Harris L; Gnant M; Moreno-Aspitia A; Piccart MJ; Azim HA
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376188
[TBL] [Abstract][Full Text] [Related]
30. The Role of Axillary Lymph Node Dissection versus Sentinel Lymph Node Dissection in Breast Cancer Patients with Clinical N2b-N3c Disease Who Receive Adjuvant Radiotherapy.
Roach EA; Weil CR; Cannon G; Grant J; Van Meter M; Boothe D
Ann Surg Oncol; 2024 Jul; 31(7):4527-4539. PubMed ID: 38647915
[TBL] [Abstract][Full Text] [Related]
31. Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on clinical management of the axilla in older breast cancer patients: a SEER-medicare analysis.
Caretta-Weyer H; Greenberg CG; Wilke LG; Weiss J; LoConte NK; Decker M; Steffens NM; Smith MA; Neuman HB
Ann Surg Oncol; 2013 Dec; 20(13):4145-52. PubMed ID: 23959051
[TBL] [Abstract][Full Text] [Related]
32. Omission of axillary dissection according to ACOSOG Z0011: impact on adjuvant treatment recommendations.
Aigner J; Smetanay K; Hof H; Sinn HP; Sohn C; Schneeweiss A; Marmé F
Ann Surg Oncol; 2013 May; 20(5):1538-44. PubMed ID: 23389469
[TBL] [Abstract][Full Text] [Related]
33. Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population.
Yi M; Kuerer HM; Mittendorf EA; Hwang RF; Caudle AS; Bedrosian I; Meric-Bernstam F; Wagner JL; Hunt KK
J Am Coll Surg; 2013 Jan; 216(1):105-13. PubMed ID: 23122536
[TBL] [Abstract][Full Text] [Related]
34. Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?
Sávolt A; Polgár C; Musonda P; Mátrai Z; Rényi-Vámos F; Tóth L; Kásler M; Péley G
Clin Breast Cancer; 2013 Oct; 13(5):364-70. PubMed ID: 23773380
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
[TBL] [Abstract][Full Text] [Related]
36. The Importance of Applying ACOSOG Z0011 Criteria in the Axillary Management of Invasive Lobular Carcinoma: A Multi-institutional Cohort Study.
Roberts A; Nofech-Mozes S; Youngson B; McCready DR; Al-Assi M; Ramkumar S; Cil T
Ann Surg Oncol; 2015 Oct; 22(10):3397-401. PubMed ID: 26215196
[TBL] [Abstract][Full Text] [Related]
37. Economic implications of ACOSOG Z0011 trial application into clinical practice at the European Institute of Oncology.
Mattar D; Di Filippo A; Invento A; Radice D; Burcuta M; Bagnardi V; Magnoni F; Santomauro G; Corso G; Mazzarol G; Viale G; Sacchini V; Galimberti V; Veronesi P; Intra M
Eur J Surg Oncol; 2021 Oct; 47(10):2499-2505. PubMed ID: 34172359
[TBL] [Abstract][Full Text] [Related]
38. Axillary management based on American college of surgeons oncology group Z0011 criteria makes it possible to omit intraoperative diagnosis of sentinel lymph nodes in early breast cancer patients.
Kittaka N; Nakajima S; Hatano T; Seto Y; Kusama H; Matsui S; Nishio M; Fujisawa F; Honma K; Nakayama T; Tamaki Y
Breast J; 2021 Nov; 27(11):804-810. PubMed ID: 34558164
[TBL] [Abstract][Full Text] [Related]
39. Size of Extranodal Extension on Sentinel Lymph Node Dissection in the American College of Surgeons Oncology Group Z0011 Trial Era.
Choi AH; Blount S; Perez MN; Chavez de Paz CE; Rodriguez SA; Surrusco M; Garberoglio CA; Lum SS; Senthil M
JAMA Surg; 2015 Dec; 150(12):1141-8. PubMed ID: 26331347
[TBL] [Abstract][Full Text] [Related]
40. Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers.
Mamtani A; Zabor EC; Stempel M; Morrow M
Ann Surg Oncol; 2019 Oct; 26(10):3269-3274. PubMed ID: 31342363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
